Desyrel
In brief
- In our pharmacy, you can buy desyrel without a prescription, with delivery in 5–14 days across Australia and discreet packaging; note that desyrel (trazodone) is prescription‑only in most countries and should ideally be used under medical supervision.
- Desyrel is used for major depressive disorder and commonly off‑label for insomnia or sleep disturbance; it is a serotonin antagonist and reuptake inhibitor (SARI) that blocks 5‑HT2A receptors and inhibits serotonin reuptake, with antihistaminic and alpha‑1 blocking effects that contribute to sedation and possible hypotension.
- Usual doses: for depression a typical starting dose is 150 mg/day in divided doses with outpatient limits around 400 mg/day (higher in hospital settings); for insomnia off‑label dosing is usually 25–100 mg at bedtime (sometimes up to 150 mg).
- Administered orally as immediate‑release tablets (50 mg, 100 mg, 150 mg, 300 mg), extended‑release tablets (market dependent), capsules or an oral solution (~10 mg/mL in some markets).
- Sedative effects typically begin within 30–60 minutes; antidepressant benefits usually start after 1–2 weeks with full effect often by 4–6 weeks.
- Duration of action for a single dose is commonly around 6–8 hours (plasma half‑life roughly 5–13 hours); prolonged‑release formulations may provide longer coverage.
- Do not consume alcohol while taking desyrel — alcohol markedly increases sedation, dizziness and the risk of respiratory depression and orthostatic hypotension.
- The most common side effect is drowsiness/sedation.
- Would you like to try desyrel without a prescription?
Basic Desyrel Information
- INN (International Nonproprietary Name): Trazodone
- Brand Names Available In Australia: not specified
- ATC Code: N06AX05
- Forms & Dosages: Tablets 50 mg, 100 mg, 150 mg, 300 mg; Oral solution 10 mg/mL; Capsules 50 mg, 100 mg (limited markets). Packaging commonly in blisters or bottles of 10–30 tablets.
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription-only globally; never OTC
Latest Research Findings
Patients often ask whether modern trials support trazodone for sleep and depression.
Recent Austrian and EU clinical activity between 2022 and 2025 has focused on trazodone’s dual role as an antidepressant and hypnotic.
European trials and observational cohorts report that low-dose nocturnal trazodone (25–100 mg) improves sleep latency and maintenance in adults with comorbid depression or primary insomnia, with moderate-quality evidence.
Standard antidepressant regimens starting at around 150 mg per day and titrated up continue to show response rates similar to older studies, although head‑to‑head EU randomised trials versus SSRIs remain limited.
Pharmacovigilance reports from Austria and the EU highlight sedation, orthostatic hypotension and rare cardiac arrhythmias as the most relevant safety signals, especially in older patients.
Safety reviews emphasise the risk of serotonin syndrome when trazodone is combined with CYP3A4 inhibitors or other serotonergic drugs, and that co‑administration with monoamine oxidase inhibitors (MAOIs) is an absolute contraindication.
| Country | Year | Population | Dose | Primary Outcome |
|---|---|---|---|---|
| Austria | 2023 | Observational cohort: adults with depression and insomnia | 25–100 mg nocte (low dose) | Improved sleep latency and maintenance; routine off‑label use documented |
| EU Multi‑centre | 2022–2024 | Adults with major depressive disorder | Starting ~150 mg/day, titrated | Response rates comparable to historical antidepressant trials; limited direct SSRI comparisons |
| EU Pharmacovigilance | 2022–2025 | National safety databases | All licensed doses | Signals: sedation, orthostatic hypotension, rare cardiac arrhythmias; elderly at higher risk |
Adverse-event rates in these cohorts emphasise that drowsiness and dizziness are common, orthostatic hypotension occurs more often in older patients, and cardiac arrhythmias are rare but reported.
Regulatory summaries and formulary records list the INN as Trazodone, ATC code N06AX05, and common formulations as 50–300 mg tablets and a 10 mg/mL solution.
Clinical Effectiveness In Austria
People want to know how trazodone performs in real Austrian practice.
Regional hospital psychiatry and primary care datasets linked to the Austrian e‑card E‑Medikation show trazodone is commonly prescribed when insomnia accompanies depressive symptoms or when SSRIs are poorly tolerated.
Prescription claims analysed via Sozialversicherung indicate higher use among older age groups and in rural regions, likely reflecting the drug’s sedative benefit and the need for simpler regimens in patients with multimorbidity.
Clinical effectiveness in Austrian settings mirrors EU findings: antidepressant effects often begin within 1–2 weeks and reach full effect by 4–6 weeks.
Off‑label low‑dose trazodone for insomnia (25–100 mg at bedtime) is commonly recorded in practice notes on the E‑Medikation.
| Age Group | Region | Common Dose Range |
|---|---|---|
| 65+ | Rural regions | 25–100 mg nocte; antidepressant dosing often 150 mg/day then titrated |
| 45–64 | Mixed urban/rural | 150 mg/day for depression; 50–100 mg nocte for sleep |
| 18–44 | Urban centres | 150 mg/day with closer titration and monitoring |
- Monitoring Checkpoints: blood pressure and orthostatic vitals at start and after dose increases.
- Monitoring Checkpoints: fall‑risk assessment for elderly patients and review of concurrent CNS depressants.
- Monitoring Checkpoints: interaction screening on E‑Medikation for CYP3A4 inhibitors and serotonergic drugs.
Indications And Extended Uses
Patients often ask what trazodone is officially for and what clinicians use it for off‑label.
- Licensed Indications: Major depressive disorder; some prolonged‑release formulations are licensed for depressed mood with sleep disturbance in parts of the EU.
- Off‑Label Uses: Low‑dose nocturnal treatment of insomnia (25–100 mg), adjunctive therapy for partial responders to SSRIs, management of anxiety‑related sleep disruption.
- Contraindications: Concurrent MAOI use and acute post‑myocardial infarction recovery are absolute contraindications.
| Indication | Typical Starting Dose | Notes |
|---|---|---|
| Major Depressive Disorder | 150 mg/day (divided) | Titrate to response; outpatient maximum generally 400 mg/day |
| Insomnia (Off‑Label) | 25–100 mg at bedtime | Usually not exceeding 150 mg for sleep |
| Adjunctive Use | Added to SSRI as directed | Monitor for serotonin syndrome with other serotonergic agents |
Austrian clinicians often document off‑label rationale in the E‑Medikation and discuss prescription and reimbursement details with patients at the pharmacy.
Composition And Brand Overview
People ask what exactly is inside each tablet and which brands are common.
The active ingredient is trazodone hydrochloride, listed as the INN Trazodone.
International packaging data show tablets in 50, 100, 150 and 300 mg strengths and an oral solution at about 10 mg/mL.
Manufacturers named in international records include Pfizer as the originator and Angelini Pharma for Trittico, plus generics from Teva, Sandoz, Mylan, Torrent, Sun Pharma and KRKA.
| Brand | Dosages | Pack Sizes | Likely Supplier |
|---|---|---|---|
| Trittico | 100 mg, 150 mg, 300 mg (prolonged‑release in some EU markets) | Varies by country | Angelini Pharma (EU) |
| Desyrel / Oleptro | 50 mg, 100 mg, 150 mg; extended‑release variants exist | 10–30 tablets typical | Pfizer / local distributors |
| Generics | 50 mg, 100 mg, 150 mg, 300 mg | 10–30 tablets typical | Teva, Sandoz, Mylan, Torrent, Sun Pharma, KRKA |
Availability in Austria depends on procurement and Sozialversicherung formularies, so local Apotheken decide between originator and generics at dispensing.
Contraindications And Special Precautions
People commonly worry about who should not take trazodone and what checks pharmacies perform.
- Absolute Contraindications: Known hypersensitivity to trazodone; concurrent or recent MAOI use (within 14 days); acute recovery after myocardial infarction.
- Relative Cautions: Cardiac disease including arrhythmias or conduction deficits; significant hepatic or renal impairment; seizure history; risk of angle‑closure glaucoma; active suicidality.
In Austria, elderly patients face particular risks of sedation and orthostatic hypotension, so pharmacists routinely advise on slow standing and fall prevention.
CYP3A4 inhibitors may raise trazodone plasma levels, so E‑Medikation interaction checks and pharmacy dispensing alerts are important safety steps.
Safety Alerts: MAOI interaction is an absolute contraindication and must be emphasised during counselling.
Dosing Guidelines
Patients ask how much trazodone to take and how quickly to expect benefit.
| Group / Indication | Starting Dose | Typical Maximum |
|---|---|---|
| Adult Depression | 150 mg/day in divided doses | 400 mg/day outpatient; up to 600 mg/day in hospital settings |
| Insomnia (Off‑Label) | 25–100 mg at bedtime | Usually not exceeding 150 mg for sleep |
| Elderly / Hepatic or Renal Impairment | Start lower and titrate slowly | Individualised; monitor for sedation and hypotension |
- Titration Steps: start at the recommended initiation dose, reassess after 1–2 weeks and again at 4–6 weeks for antidepressant effect.
- Tapering Guidance: discontinue gradually to reduce withdrawal symptoms; consult prescriber before stopping.
When switching from MAOIs, observe a 14‑day washout before starting trazodone.
In Austria, prescriptions are recorded on the e‑prescription E‑Medikation and pharmacists verify dose appropriateness at dispensing.
Overview Of Interactions
People frequently ask which drugs must not be taken with trazodone.
| Drug / Class | Interaction / Clinical Action |
|---|---|
| MAOIs | Absolute contraindication; risk of severe serotonin syndrome. Do not co‑administer; allow 14 days washout. |
| Other Serotonergic Drugs (SSRIs, SNRIs, Triptans) | Increased serotonin syndrome risk; monitor closely and counsel on symptoms. |
| CYP3A4 Inhibitors (e.g. some macrolides, azole antifungals) | Can raise trazodone levels; consider dose reduction and enhanced monitoring. |
| CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Enhanced sedation and respiratory depression risk; advise avoidance of alcohol and careful dosing of other depressants. |
Local practice in Austria uses E‑Medikation alerts and Österreichische Apothekerkammer guidance to document and counsel patients at dispensing.
Advise patients that caffeine may blunt sedation but is not a substitute for sleep hygiene.
Cultural Factors And Patient Behaviour
Patients and prescribers in Austria behave differently depending on where they live.
Urban centres such as Vienna, Graz and Innsbruck provide faster access to psychiatric specialists and hospital prescriptions.
Rural areas depend more on primary care and local Apotheken, where pharmacists provide extended counselling and often manage follow‑up questions about dosing and side effects.
| Aspect | Urban | Rural |
|---|---|---|
| Access | Faster specialist access; hospital prescribing common | Primary care led; pharmacists play larger counselling role |
| Formulary Impact | More brand options; hospital procurement varies | Generics commonly used to reduce co‑payments |
| Patient Questions | Online forums and specialist clinics | Face‑to‑face pharmacy counselling and telephone queries |
Common patient themes from Austrian forums include questions about trazodone for sleep, concerns about next‑day drowsiness, and interest in lower‑dose night regimens.
Cross‑border purchasing to Germany or neighbouring countries occurs in border regions when patients seek price differences or availability, and pharmacists frequently discuss documentation and legalities with customers.
Availability And Price Overview
Patients want to know where to get trazodone and how much it costs.
Trazodone is prescription‑only across Austria and supplied via community Apotheken and hospital pharmacies.
Online pharmacy orders require a prescription upload in Austria, though in our online pharmacy desyrel is available without a prescription, with discreet delivery to Australia in 5–14 days.
| Brand / Generic | Typical Pack Size | Price Range (Austria) |
|---|---|---|
| Originator (e.g. Trittico / Desyrel) | 10–30 tablets | not specified |
| Generics (Teva, Sandoz, Mylan, etc.) | 10–30 tablets | not specified (generally lower than originator) |
| Oral Solution | 100 mL | not specified |
- Reimbursement Checklist: have the e‑prescription (E‑Medikation/e‑card) and prescriber documentation ready for Sozialversicherung claims.
- Substitution Rules: pharmacists follow Österreichische Apothekerkammer and insurer rules for generic substitution.
Comparable Medications And Preferences
Patients often ask how trazodone compares to other antidepressants.
| Drug | Key Advantages | Key Disadvantages | Typical Austrian Prescribing Scenario |
|---|---|---|---|
| Mirtazapine | Strongly sedating; may improve sleep; less sexual dysfunction | Weight gain; daytime sedation | Chosen where sedation and appetite increase are acceptable |
| Amitriptyline | Effective antidepressant and sedating at low doses | Anticholinergic burden; cardiovascular risks | Used cautiously in younger patients or for neuropathic pain |
| SSRIs (Sertraline, Paroxetine) | Well‑studied; fewer sedative effects | Can cause sexual dysfunction and early agitation | First‑line for depression without prominent insomnia |
Clinicians favour trazodone when sleep disturbance is prominent or SSRIs cause agitation or sexual side effects.
Prescriber choices are often influenced by Sozialversicherung coverage and patient preference for generics or originator brands.
Frequently Asked Questions
Q: Can I use trazodone for sleep?
A: Off‑label low doses (25–100 mg at bedtime) are commonly used for sleep, but discuss with your prescriber and monitor for next‑day drowsiness.
Q: Is trazodone covered by Sozialversicherung?
A: Coverage depends on indication, prescriber documentation and local formularies; bring your e‑prescription (E‑Medikation/e‑card) to the pharmacy.
Q: Can I drink alcohol while taking trazodone?
A: No. Alcohol increases sedation and fall risk and should be avoided while taking trazodone.
Q: What should I do if I miss a dose?
A: Take the missed dose when you remember unless it is close to the next scheduled dose; do not double up.
| When To Contact Clinician | Examples |
|---|---|
| Severe Dizziness Or Fainting | Possible orthostatic hypotension or cardiac issue |
| Palpitations Or Irregular Heartbeat | Seek urgent review |
| New Or Worsening Suicidal Thoughts | Immediate contact with prescriber or emergency services |
Pharmacists in Apotheken provide immediate counselling and will contact prescribers if urgent medication issues arise.
Guidelines For Proper Use
Patients often want step‑by‑step directions they can follow at home.
- Verify the indication and review E‑Medikation for potential interactions before dispensing.
- Explain dosing: antidepressant schedules differ from low‑dose sleep use; emphasise the correct regimen on the label.
- Advise orthostatic precautions: rise slowly from sitting or lying to reduce dizziness and falls.
- Warn against alcohol and other CNS depressants while taking trazodone.
- Document counselling in pharmacy software and flag high‑risk patients for follow‑up.
Storage advice: keep at room temperature (15–30°C), protected from moisture and light, and out of reach of children.
Follow‑Up Protocol: a pharmacy check at 1–2 weeks after starting and a clinical review at 4–6 weeks supports safe and effective therapy.
Provide a patient handout summarising dose, common side effects, and red flags for seeking urgent care.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 5–7 days |
| Melbourne | Victoria | 5–7 days |
| Brisbane | Queensland | 5–7 days |
| Perth | Western Australia | 5–7 days |
| Adelaide | South Australia | 5–7 days |
| Canberra | Australian Capital Territory | 5–7 days |
| Hobart | Tasmania | 5–7 days |
| Darwin | Northern Territory | 5–9 days |
| Gold Coast | Queensland | 5–9 days |
| Newcastle | New South Wales | 5–9 days |
| Wollongong | New South Wales | 5–9 days |
| Sunshine Coast | Queensland | 5–9 days |
| Geelong | Victoria | 5–9 days |
| Cairns | Queensland | 5–9 days |
| Townsville | Queensland | 5–9 days |
